CrystecPharma

Pharmaceutical Manufacturing • Bradford, England, United Kingdom • 11-20 Employees

Company overview

Headquarters	Norcroft Building, Richmond Road, Bradford, BD7 1DP, GB
Phone number	+441274235592
Website	crystecpharma.com
NAICS	3254
SIC	283
Employees	11-20
Socials

Key Contacts at CrystecPharma

Lyn Daintree

Development Director

Paul Thorning

Ceo

George Townend

Director Of Engineering

CrystecPharma Email Formats

CrystecPharma uses 2 email formats. The most common is {first initial}.{last name} (e.g., j.doe@crystecpharma.com), used 77.8% of the time.

Format	Example	Percentage
{first initial}.{last name}	j.doe@crystecpharma.com	77.8%
{first name}.{last name}	john.doe@crystecpharma.com	22.2%

About CrystecPharma

Crystec Pharma is focused on applying supercritical fluid technology to improve the performance of medicines. We provide crystal and particle engineering solutions to the pharmaceutical industry, contributing to human health by enabling new and more effective therapies. Applications of our mSAS® (modified Supercritical Anti-Solvent) technology include enhancing the dissolution and bioavailability of drugs, optimising release profiles, as well as improving stability and processing characteristics. Our solutions include the following: • Crystal and particle engineering • Stabilisation of therapeutic agents derived from biotechnology • Polymorph screening • Improved performance of poorly soluble drugs • Improved bioavailabilty of small molecules • Alternative routes of delivery such as inhaled therapy • Taste masking • Crystallisation seeds • Residual solvent elimination

CrystecPharma revenue & valuation

Annual revenue	$1,711,100
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues	$5,500,000
Total funding	No funding